Efficacy and Safety Study of Ryanodex as Adjuvant Treatment in Subjects With Psychostimulant Drug-Induced Toxicity (PDIT)
Clinical trial NCT03189433 · TERMINATED
Trial details
- NCT number
- NCT03189433
- Sponsor
- Eagle Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-12
- Primary completion
- 2018-12-31
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.